Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 241-252 of 9489

Pictured at the expanded Histotripsy Training Center in Hong Kong. Front row (left to right): Dr. Angus Yuen, Chief Medical Officer, Gleneagles Hospital Hong Kong; Prof. Albert Chan, Director of Liver Cancer Surgery Centre, Gleneagles Hospital Hong Kong; Dr. Kenneth Tsang, Regional Chief Executive Officer, IHH Healthcare North Asia, and Chief Executive Officer, Gleneagles Hospital Hong Kong; Dr. Vince Lau, Director of Interventional Radiology Centre, Gleneagles Hospital Hong Kong; Dr. Joe Herman, Vice President, Medical Affairs, HistoSonics. Back row (left to right): Jay Lee, APAC Regional Manager, HistoSonics; Eric Kwong, Hong Kong Sales Manager, Transmedic; Matt Brown, Director of OUS Professional Education, HistoSonics.

HistoSonics Opens Expanded Histotripsy Training Center in Hong Kong

Business Wire logo

Clinigen Appoints Greg Skalicky as Chief Executive Officer

Business Wire logo

Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)

PR Newswire associated0

Medtrum Advances 300U Tubeless Patch Pump Toward German Launch

PR Newswire associated0

Bracco Imaging Earns Second Consecutive EcoVadis Platinum Medal with Record Sustainability Score

Business Wire logo

Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region

Business Wire logo

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers

Children’s health further protected with energy drinks ban

Business Wire logo

Aqemia and Sanofi Expand Their Research Collaboration

First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA

  • Prev Page
  • 1
  • 2
  • …
  • 20
  • 21
  • 22
  • …
  • 790
  • 791
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us